Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-29 01:35:42 - browse：161

An AstraZeneca sign at ESMO in Madrid. — An AstraZeneca ad at ESMO 2023 in Madrid. Andrew Joseph/STAT

MADRID — Questions about one of AstraZeneca’s key cancer drug candidates — and the dribs and drabs that have come out about its performance — have been dogging the company for months.

On Monday, data presented here from a trial of the drug in advanced non-small cell lung cancer provided at least a fuller look. While the results assuaged some of the safety fears that flared when initial information was released over the summer, they only heightened concerns about the drug’s ability to outperform standard chemotherapy — though they perhaps pointed to an opportunity for the drug in a subset of patients.

The trial, detailed here in a prime session at the annual meeting of the European Society for Medical Oncology, is testing a therapy called datopotamab deruxtecan, or Dato-DXd, in advanced or metastatic non-small cell lung cancer in patients who already tried at least first-line treatments. Patients were randomized to either receive chemotherapy or Dato-DXd, which AstraZeneca is developing with Daiichi Sankyo.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Anavex keeps shifting the goalposts in its clinical trials

WSS

Police still searching for prisoner who escaped from NYC hospital

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Emergent cuts jobs, executive role in business shake

How to use technology to prevent future drug shortages

FDA panel issues narrow recommendation for Covid vaccine booster doses

knowledge

Wikipedia

entertainment

Peter Hotez and the public health issue of online harassment

Biden administration sends mixed signals on US soldier who crossed into North Korea

Jerome Adams on the need for new antivirals for Covid

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

BioMarin wins approval for gene therapy to treat hemophilia A

Why you get paid to donate plasma but not blood

George Santos makes 1st court appearance after pleading not guilty to 13 counts

BridgeBio heart drug succeeds in pivotal study

Alkermes shareholders re

South Korea throws huge K

knowledge

In same hospitals, Black patients receive fewer opioids than white patients

How to use technology to prevent future drug shortages

In same hospitals, Black patients receive fewer opioids than white patients

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Maui's cultural, historic landmarks damaged in the devastating wildfires

The best solution to the drug shortages problem

focus

focus

leisure time

knowledge